Clinical Trial Update: Exhaled Breath Condensate Biomarkers and Cough in IPF

View source ↗

Summary

This update summarizes findings from a completed trial investigating exhaled breath condensate biomarkers and cough in idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Snippet

Sponsor: University of East Anglia | Conditions: Idiopathic Pulmonary Fibrosis | Status: COMPLETED